191 related articles for article (PubMed ID: 31619134)
1. Leptomycin B inhibits the proliferation, migration, and invasion of cultured gastric carcinoma cells.
Zhu H; Yang Y; Wang L; Xu X; Wang T; Qian H
Biosci Biotechnol Biochem; 2020 Feb; 84(2):290-296. PubMed ID: 31619134
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of the nuclear export protein, Crm1 (exportin 1), associates with human oesophageal squamous cell carcinoma.
van der Watt PJ; Zemanay W; Govender D; Hendricks DT; Parker MI; Leaner VD
Oncol Rep; 2014 Aug; 32(2):730-8. PubMed ID: 24898882
[TBL] [Abstract][Full Text] [Related]
3. Nuclear entrapment of p33ING1b by inhibition of exportin-1: A trigger of apoptosis in head and neck squamous cell cancer.
Özdaş S
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):66-72. PubMed ID: 29729696
[TBL] [Abstract][Full Text] [Related]
4. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
Meissner T; Krause E; Vinkemeier U
FEBS Lett; 2004 Oct; 576(1-2):27-30. PubMed ID: 15474004
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy.
Gao W; Lu C; Chen L; Keohavong P
J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636
[TBL] [Abstract][Full Text] [Related]
6. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
[TBL] [Abstract][Full Text] [Related]
7. Leptomycin B alters the subcellular distribution of CRM1 (Exportin 1).
Rahmani K; Dean DA
Biochem Biophys Res Commun; 2017 Jun; 488(2):253-258. PubMed ID: 28412356
[TBL] [Abstract][Full Text] [Related]
8. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.
Kimura T; Hashimoto I; Nagase T; Fujisawa J
J Cell Sci; 2004 May; 117(Pt 11):2259-70. PubMed ID: 15126627
[TBL] [Abstract][Full Text] [Related]
9. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression.
Jang BC; Muñoz-Najar U; Paik JH; Claffey K; Yoshida M; Hla T
J Biol Chem; 2003 Jan; 278(5):2773-6. PubMed ID: 12468543
[TBL] [Abstract][Full Text] [Related]
10. Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.
Sexton R; Mahdi Z; Chaudhury R; Beydoun R; Aboukameel A; Khan HY; Baloglu E; Senapedis W; Landesman Y; Tesfaye A; Kim S; Philip PA; Azmi AS
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569391
[TBL] [Abstract][Full Text] [Related]
11. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-alpha/beta and chromosomal region maintenance 1/exportin 1.
Pickard BW; Hodsman AB; Fraher LJ; Watson PH
Endocrinology; 2007 May; 148(5):2282-9. PubMed ID: 17317770
[TBL] [Abstract][Full Text] [Related]
12. CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity.
Sakakibara K; Saito N; Sato T; Suzuki A; Hasegawa Y; Friedman JM; Kufe DW; Vonhoff DD; Iwami T; Kawabe T
Blood; 2011 Oct; 118(14):3922-31. PubMed ID: 21841164
[TBL] [Abstract][Full Text] [Related]
13. Alpha, 2'-dihydroxy-4,4'-dimethoxydihydrochalcone inhibits cell proliferation, invasion, and migration in gastric cancer in part via autophagy.
Wan B; Zhu J; Chang Q; Zhou H; Shi Z; Min L; Cai Y; Guan H
Biomed Pharmacother; 2018 Feb; 98():709-718. PubMed ID: 29306208
[TBL] [Abstract][Full Text] [Related]
14. A low toxic CRM1 degrader: Synthesis and anti-proliferation on MGC803 and HGC27.
Xu HW; Jia S; Liu M; Li X; Meng X; Wu X; Yu L; Wang M; Jin CY
Eur J Med Chem; 2020 Nov; 206():112708. PubMed ID: 32810752
[TBL] [Abstract][Full Text] [Related]
15. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export.
Strunze S; Trotman LC; Boucke K; Greber UF
Mol Biol Cell; 2005 Jun; 16(6):2999-3009. PubMed ID: 15814838
[TBL] [Abstract][Full Text] [Related]
16. Crm1 is a mitotic effector of Ran-GTP in somatic cells.
Arnaoutov A; Azuma Y; Ribbeck K; Joseph J; Boyarchuk Y; Karpova T; McNally J; Dasso M
Nat Cell Biol; 2005 Jun; 7(6):626-32. PubMed ID: 15908946
[TBL] [Abstract][Full Text] [Related]
17. Identification of nuclear export inhibitors with potent anticancer activity in vivo.
Mutka SC; Yang WQ; Dong SD; Ward SL; Craig DA; Timmermans PB; Murli S
Cancer Res; 2009 Jan; 69(2):510-7. PubMed ID: 19147564
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
Schütz SV; Cronauer MV; Rinnab L
J Cell Biochem; 2010 Apr; 109(6):1192-200. PubMed ID: 20127713
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death.
Fabi F; Adam P; Vincent K; Demontigny F; Parent S; Joncas FH; Asselin E
Cell Commun Signal; 2018 Jul; 16(1):39. PubMed ID: 29973205
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.
Henderson BR; Eleftheriou A
Exp Cell Res; 2000 Apr; 256(1):213-24. PubMed ID: 10739668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
